| 题名 | Nonclinical toxicology assessments support the chronic safety of dapagliflozin, a first-in-class sodium-glucose cotransporter 2 inhibitor |
| 杂志 | International Journal of Toxicology (2013), 32(5), 336-350, 15. |
| 链接 | http://ijt.sagepub.com/content/early/2013/10/03/1091581813505331.full.pdf |
| 欢迎光临 科研速递论坛 (http://www.expaper.cn/) | Powered by Discuz! X2.5 |